Top Markets
#1 Black Phoenix Black Phoenix +823.38%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.27%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.33%
#4 Prom Prom +20.84%
#5 Beam Beam +20.03%
#6 SAFEcoin SAFEcoin +19.77%
#7 Magma Finance Magma Finance +19.58%
#8 Bless Bless +17.25%
#9 pipedog pipedog +16.97%
#10 YFSX YFSX +16.05%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
株式のランク #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
株価
$45.79
時価総額
$2.33B
変化（1日）
11.43%
変化（1年）
408.10%
国
FR
取引 Nanobiotix S.A. (NANO)

カテゴリー

Healthcare
Nanobiotix S.A.（NANO）の株価履歴
終値の最高値: $41.65 （2026-08-01）

終値の最安値: $8.60 （2012-10-01）
Nanobiotix S.A. の株価履歴（2012 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.16 41.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.18%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.75 468.71%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH